Epithelioid sarcoma

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:293202C49.9
Who is this for?
Show terms as
1FDA treatments4Active trials53Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Epithelioid sarcoma is a rare type of soft tissue cancer (sarcoma) that most often develops in the hands, fingers, forearms, or feet of young adults. Unlike many other sarcomas, it tends to grow slowly and can initially look like a harmless lump, cyst, or non-healing wound, which often leads to delays in diagnosis. The tumor is made up of cells that look similar to epithelial cells (the cells that line the surfaces of your body) under a microscope, which is how it gets its name. There are two main forms of this disease. The classic or distal type usually appears in the arms or legs of younger patients, often as a firm, painless nodule under the skin. The proximal type tends to occur in older patients and affects deeper tissues in areas like the pelvis, groin, or trunk. The proximal type generally behaves more aggressively. A hallmark of epithelioid sarcoma is the loss of a tumor suppressor protein called INI1 (also known as SMARCB1), which helps doctors confirm the diagnosis. Treatment typically involves surgery to remove the tumor with wide margins, often combined with radiation therapy. For advanced or metastatic disease, the FDA-approved drug tazemetostat (Tazverik) targets the specific molecular pathway involved. Despite treatment, epithelioid sarcoma has a tendency to come back locally and can spread to lymph nodes and lungs, making long-term follow-up essential.

Key symptoms:

Firm, slow-growing lump under the skinPainless nodule on the hand, finger, forearm, or footA wound or ulcer that does not healLump that may be mistaken for a cyst or wartSwelling in the affected areaPain or tenderness as the tumor growsNumbness or tingling if nerves are affectedRestricted movement of a nearby jointSwollen lymph nodes near the tumorDeep mass in the pelvis, groin, or trunk (proximal type)Unexplained weight loss in advanced diseaseShortness of breath if cancer spreads to the lungs

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

4 events
Dec 2025A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

Memorial Sloan Kettering Cancer Center — PHASE2

TrialRECRUITING
Sep 2020Evaluate the Safety and Clinical Activity of HH2853

Haihe Biopharma Co., Ltd. — PHASE1, PHASE2

TrialRECRUITING
Oct 2019Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care

Kantonsspital Winterthur KSW

TrialRECRUITING
Aug 2017An Observational Study on Epithelioid Sarcoma

Italian Sarcoma Group

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Tazverik

tazemetostat· Epizyme, Inc.Accelerated Approval

Adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection.

Clinical Trials

4 recruitingView all trials with filters →
Phase 21 trial
A Study of Pembrolizumab in People With Ultra-Rare Sarcomas
Phase 2
Actively Recruiting
PI: Robert Maki, MD, MPH (Memorial Sloan Kettering Cancer Center) · Sites: Basking Ridge, New Jersey; Middletown, New Jersey +4 more · Age: 1899 yrs
Other2 trials
An Observational Study on Epithelioid Sarcoma
Actively Recruiting
PI: Paolo Casali, MD (Fondazione IRCCS INT Milano) · Sites: Meldola, FC; Milan, MI +9 more
Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care
Actively Recruiting
PI: Bruno Fuchs, Prof (SwissSarcomaNetwork) · Sites: Winterthur, Canton of Zurich; Winterthur, Canton of Zurich +6 more

Specialists

Showing 25 of 53View all specialists →
XZ
Xing Zhang
PAOLI, PA
Specialist
PI on 4 active trials
RP
Robert Maki, MD, PhD
PHILADELPHIA, PA
Specialist
PI on 8 active trials
SP
Scott Schuetze, MD, PhD
ANN ARBOR, MI
Specialist
PI on 3 active trials
SP
Sandip P Patel
Birmingham, Alabama
Specialist

Rare Disease Specialist

PI on 1 active trial
AW
Aaron R Weiss
Specialist
PI on 1 active trial56 Epithelioid sarcoma publications
ZX
Zhang Xing
Specialist
PI on 1 active trial9 Epithelioid sarcoma publications
RM
Robert Maki
PHILADELPHIA, PA
Specialist
PI on 1 active trial6 Epithelioid sarcoma publications
SM
Suzanne Forrest, MD
Specialist
PI on 1 active trial
RM
Robert Maki, MD, MPH
PHILADELPHIA, PA
Specialist
PI on 1 active trial
CB
Ciara Kelly, MBBCh BAO
Specialist
PI on 2 active trials9 Epithelioid sarcoma publications
GP
Gregory Cote, MD, PhD
BOSTON, MA
Specialist
PI on 1 active trial
PM
Paolo Casali, MD
Specialist
PI on 2 active trials
MM
Mary L. Keohan, MD
NEW YORK, NY
Specialist
PI on 1 active trial
PS
Paul Savage
Specialist
PI on 1 active trial
SM
Susan Chi, MD
Specialist
PI on 2 active trials
JM
Jordan Milner, MD
GAINESVILLE, FL
Specialist
PI on 5 active trials
MM
Mary F Wedekind Malone
Specialist
PI on 1 active trial18 Epithelioid sarcoma publications
JB
Javier Martín Broto
Specialist
PI on 2 active trials
GG
Giovanni Grignani
Specialist
PI on 2 active trials4 Epithelioid sarcoma publications
AR
Andrés Redondo
Specialist
PI on 2 active trials5 Epithelioid sarcoma publications
RC
Rashmi Chugh
ANN ARBOR, MI
Specialist
PI on 1 active trial12 Epithelioid sarcoma publications
JC
Josefina Cruz
PHILADELPHIA, PA
Specialist
PI on 1 active trial23 Epithelioid sarcoma publications
SS
Silvia Stacchiotti
Specialist
PI on 2 active trials9 Epithelioid sarcoma publications
NM
Neeta Somaiah, MBBS
HOUSTON, TX
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Epithelioid sarcoma.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Epithelioid sarcomaForum →

No community posts yet. Be the first to share your experience with Epithelioid sarcoma.

Start the conversation →

Latest news about Epithelioid sarcoma

Disease timeline:

New recruiting trial: Evaluate the Safety and Clinical Activity of HH2853

A new clinical trial is recruiting patients for Epithelioid sarcoma

New recruiting trial: An Observational Study on Epithelioid Sarcoma

A new clinical trial is recruiting patients for Epithelioid sarcoma

New recruiting trial: A Study of Pembrolizumab in People With Ultra-Rare Sarcomas

A new clinical trial is recruiting patients for Epithelioid sarcoma

New recruiting trial: Swiss Sarcoma Network: Prediction Model for Patient Selection in Sarcoma Care

A new clinical trial is recruiting patients for Epithelioid sarcoma

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What type of epithelioid sarcoma do I have — classic (distal) or proximal — and how does that affect my outlook?,Has the tumor been tested for INI1/SMARCB1 loss to confirm the diagnosis?,Can the tumor be completely removed with surgery, and what will the impact be on my function?,Do I need radiation therapy after surgery, and what are the side effects?,Am I a candidate for tazemetostat or any clinical trials?,How often will I need follow-up scans, and for how long?,Should I be seen at a specialized sarcoma center for a second opinion?

Common questions about Epithelioid sarcoma

What is Epithelioid sarcoma?

Epithelioid sarcoma is a rare type of soft tissue cancer (sarcoma) that most often develops in the hands, fingers, forearms, or feet of young adults. Unlike many other sarcomas, it tends to grow slowly and can initially look like a harmless lump, cyst, or non-healing wound, which often leads to delays in diagnosis. The tumor is made up of cells that look similar to epithelial cells (the cells that line the surfaces of your body) under a microscope, which is how it gets its name. There are two main forms of this disease. The classic or distal type usually appears in the arms or legs of younger

How is Epithelioid sarcoma inherited?

Epithelioid sarcoma follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Epithelioid sarcoma typically begin?

Typical onset of Epithelioid sarcoma is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Epithelioid sarcoma?

Yes — 4 recruiting clinical trials are currently listed for Epithelioid sarcoma on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Epithelioid sarcoma?

25 specialists and care centers treating Epithelioid sarcoma are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Epithelioid sarcoma?

1 patient support program are currently tracked on UniteRare for Epithelioid sarcoma. See the treatments and support programs sections for copay assistance, eligibility, and contact details.